Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent

Critical Care Medicine

Volumn 27, Issue 11, 1999, Pages 2563-2568

  Sullivan, Kevin J ^a   Goodwin, Salvatore R ^a   Evangelist, Jennifer ^a   Moore, Robert D ^a   Mehta, Paulette ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Acute chest syndrome; Nitric oxide; Sickle cell disease

Indexed keywords

HEMOGLOBIN S; NITRIC OXIDE;

ACUTE CHEST SYNDROME; ADOLESCENT; ARTICLE; CASE REPORT; EXCHANGE BLOOD TRANSFUSION; HEART OUTPUT; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; LUNG ALVEOLUS OXYGEN TENSION; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG INFILTRATE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SICKLE CELL ANEMIA; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME;

EID: 0032738619     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199911000-00039     Document Type: Article

References (36)

1. 1. Vichinsky E, Styles L: Pulmonary complications. Hematol Oncol Clin North Am 1996; 10:1275-1287
2. 2. Rossaint R, Falke KJ, Lopez F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
3. 3. Gries A, Böttiger BW, Dörsam J, et al: Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigs. Anesthesiology 1997; 86:387-393
4. 4. Head CA, Brugnara C, Martinez-Ruiz R: Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest 1997; 100:1193-1198
5. 5. Vichinsky E, Williams R, Das M, et al: Pulmonary fat embolism: A distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994; 83:3107-3111
6. 6. National Acute Chest Study Group: Acute chest syndrome (ACS) in sickle cell disease (SCD). Blood 1994; 10(Suppl):219a
7. 7. Bhalla M, Abboud MR, McLoud TC, et al: Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion. Radiology 1993; 187:45-49
8. 8. Shubin J, Kaufman R, Shapiro M, et al: Cardiovascular findings in children with sickle cell anemia. Am J Cardiol 1960; 6:875-885
9. 9. Rubler S, Fleischer RA: Sickle cell states and cardiomyopathy: Sudden death due to pulmonary thrombosis and infarction. Am J Cardiol 1967; 19:867-872
10. 10. Sutton LL, Castro O, Cross DJ, et al: Pulmonary hypertension in sickle cell disease. Am J Cardiol 1994; 74:626-628
11. 11. Bowen EF, Crowston JG, De Ceulaer K, et al: Peak expiratory flow rate and the acute chest syndrome in homozygous sickle cell disease. Arch Dis Child 1991; 66:330-332
12. 12. Powars D, Weidman JA, Odom-Maryon T, et al: Sickle cell chronic lung disease: Prior morbidity and the risk of pulmonary failure. Medicine 1988; 67:66-76
13. 13. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323:27-36
14. ++-activated K channels and contraction of cultured smooth muscle of porcine coronary artery. J Pharmacol Exp Ther 1991; 256:371-377
15. 15. Mehta P: Significance of plasma β-thromboglobulin values in patients with sickle cell disease. J Pediatr 1980; 97:941-944
16. 16. Longenecker GL, Beyers BJ, Mankad VN: Platelet regulatory prostanoids and platelet release products in sickle cell disease. Am J Hematol 1992; 40:12-19
17. 17. Kurantsin-Mills J, Ibe BO, Natta CL, et al: Elevated urinary levels of thromboxane and prostacyclin metabolites in sickle cell disease reflects activated platelets in the circulation. Br J Haematol 1994; 87:580-585
18. 18. Berney SI, Ridler CD, Stephens AD, et al: Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anaemia. Am J Hematol 1992; 40:290-294
19. 19. Haut MJ, Cowan DH, Harris JW: Platelet function and survival in sickle cell disease. J Lab Clin Med 1973; 82:44-53
20. 20. Mehta P, Mehta J: Circulating platelet aggregates in sickle cell disease in patients with and without vaso-occlusion. Stroke 1979; 10: 464-466
21. 21. Mehta P, Mehta J: Abnormalities of platelet aggregation in sickle cell disease. J Pediatr 1980; 96:209-213
22. 22. Mehta P, Albiol L: Prostacyclin and platelet aggregation in sickle cell disease. Pediatrics 1982; 70:354-356
23. 23. Hammerman SI, Kourembanas S, Conca TJ, et al: Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 1997; 156: 280-285
24. 24. Alheid U, Reichwehr I, Förstermann U: Human endothelial cells inhibit platelet aggregation by separately stimulating cyclic AMP and cyclic GMP. Eur J Pharmacol 1989; 164: 103-110
25. 25. Loscalzo J: Antiplatelet and antithrombotic effects of organic nitrates. Am J Cardiol 1992; 70:18B-22B
26. 26. Moncada S, Radomski MW, Palmer RMJ: Endothelium-derived relaxing factor: Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37:2495-2501
27. 27. Gryglewski RJ, Botting RM, Vane JR: Mediators produced by the endothelial cell. Hypertension 1988; 12:530-548
28. 28. Bath PMW, Hassall DG, Gladwin AM, et al: Nitric oxide and prostacyclin: Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb 1991; 11:254-260
29. 29. Radomski MW, Palmer RMJ, Moncada S: The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987; 148:1482-1489
30. 30. Korbut R, Lidbury PS, Vane JR: Prolongation of fibrinolytic activity of tissue plasminogen activator by nitrovasodilators. Letter. Lancet 1990; 335:669
31. 31. Zago MA, Costa FF, Ismael SJ, et al: Treatment of sickle cell diseases with aspirin. Acta Haematol 1984; 72:61-64
32. 32. Greenberg J, Ohene-Frempong K, Halus J, et al: Trial of low doses of aspirin as prophylaxis in sickle cell disease. J Pediatr 1983; 102: 781-784
33. 33. DeFuria FG, Miller DR, Cerami A, et al: The effect of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia. J Clin Invest 1972; 51:566-574
34. 34. Butler E: The effect of carbon monoxide on red cell life span in sickle cell disease. Blood 1975; 46:253-255
35. 35. Stamler JS, Jia L, Eu JP, et al: Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1997; 276:2034-2037
36. 36. Zerez C, Lachant N, Tanaka K: Impaired erythrocyte methemoglobin reduction in sickle cell disease: Dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content. Blood 1990; 76:1008-1014